Immunogenic Study for CX3CR1 Molecule in Rheumatoid Arthritis Patients
SALAMA M. EL SHINNAWY, M.D., M., HASABELNABY, M.Sc., A. (2021). Immunogenic Study for CX3CR1 Molecule in Rheumatoid Arthritis Patients. EKB Journal Management System, 89(June), 723-730. doi: 10.21608/mjcu.2021.167917
MOHAMED F. ELSHAL, M.D.* SALAMA M. EL SHINNAWY, M.D.; AHMED S. HASABELNABY, M.Sc.. "Immunogenic Study for CX3CR1 Molecule in Rheumatoid Arthritis Patients". EKB Journal Management System, 89, June, 2021, 723-730. doi: 10.21608/mjcu.2021.167917
SALAMA M. EL SHINNAWY, M.D., M., HASABELNABY, M.Sc., A. (2021). 'Immunogenic Study for CX3CR1 Molecule in Rheumatoid Arthritis Patients', EKB Journal Management System, 89(June), pp. 723-730. doi: 10.21608/mjcu.2021.167917
SALAMA M. EL SHINNAWY, M.D., M., HASABELNABY, M.Sc., A. Immunogenic Study for CX3CR1 Molecule in Rheumatoid Arthritis Patients. EKB Journal Management System, 2021; 89(June): 723-730. doi: 10.21608/mjcu.2021.167917